Clinical Trial Update: A Study of Tasisulam in Treating Participants With Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial of tasisulam in metastatic melanoma completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Tasisulam (tasisulam)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-06